Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-01-06 @ 1:12 PM
Study NCT ID:
NCT00684294
Status:
TERMINATED
Last Update Posted:
2020-03-02
First Post:
2008-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Sponsor:
Mary Crowley Medical Research Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05-27
Start Date Type:
ACTUAL
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-28
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-21
First Submit QC Date:
None
Study First Post Date:
2008-05-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-27
Last Update Post Date:
2020-03-02
Last Update Post Date Type:
ACTUAL